• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 8-A12B filed by CM Life Sciences II Inc.

    2/10/26 10:26:54 AM ET
    $CMII
    Blank Checks
    Finance
    Get the next $CMII alert in real time by email
    8-A12B 1 ea0276278-8a12b_columbus2.htm FOR REGISTRATION OF CERTAIN CLASSES

     

     

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

     

    FORM 8-A

     

     

     

    FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES

    PURSUANT TO SECTION 12(b) OR (g) OF

    THE SECURITIES EXCHANGE ACT OF 1934

     

     

     

    Columbus Circle Capital Corp II

    (Exact Name of Registrant as Specified in Its Charter)

     

     

     

    Cayman Islands   98-1890239

    (State or other jurisdiction

    of incorporation or organization)

     

    (I.R.S. Employer

    Identification No.)

       

    3 Columbus Circle, 24th Floor

    New York, NY

      10019
    (Address of Principal Executive Offices)   (Zip Code)

     

    Securities to be registered pursuant to Section 12(b) of the Act:

     

    Title of Each Class
    to be Registered

     

    Name of Each Exchange on

    Which Each Class is to be Registered

    Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant   The Nasdaq Stock Market LLC
       
    Class A ordinary shares, par value $0.0001 per share   The Nasdaq Stock Market LLC
       
    Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50   The Nasdaq Stock Market LLC

     

     

     

    If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c) or (e), check the following box. ☒

     

    If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d) or (e), check the following box. ☐

     

    If this form relates to the registration of a class of securities concurrently with a Regulation A offering, check the following box. ☐

     

    Securities Act registration statement or Regulation A offering Statement file number to which this form relates: 333-292861

     

    Securities to be registered pursuant to Section 12(g) of the Act:

     

    N/A

    (Title of Class)

     

     

     

     

     

     

    Item 1. Description of Registrant’s Securities to be Registered.

     

    The securities to be registered hereby are units, Class A ordinary shares, par value $0.0001 per share, and redeemable warrants to purchase Class A ordinary shares of Columbus Circle Capital Corp II (the “Registrant”). The description of the units, Class A ordinary shares and warrants set forth under the heading “Description of Securities” in the Registrant’s prospectus forming part of its Registration Statement on Form S-1 (File No. 333-292861), filed with the Securities and Exchange Commission on January 21, 2026, as thereafter amended and supplemented from time to time (the “Registration Statement”), to which this Form 8-A relates, is incorporated by reference herein. Any form of prospectus or prospectus supplement to the Registration Statement that includes such descriptions and that is subsequently filed is hereby also incorporated by reference herein.

     

    Item 2. Exhibits.

     

    Pursuant to the Instructions as to Exhibits for Form 8-A, no exhibits are required to be filed, because no other securities of the Registrant are registered on The Nasdaq Stock Market LLC, and the securities registered hereby are not being registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended.

     

    1

     

     

    SIGNATURE

     

    Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.

     

      Columbus Circle Capital Corp II
         
    Date: February 10, 2026 By: /s/ Gary Quin
        Name:  Gary Quin
        Title: Chief Executive Officer

     

    2

     

    Get the next $CMII alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CMII

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $CMII
    SEC Filings

    View All

    SEC Form 10-K filed by Columbus Circle Capital Corp II

    10-K - Columbus Circle Capital Corp II (0002088805) (Filer)

    3/30/26 5:29:42 PM ET
    $CMII
    Blank Checks
    Finance

    CM Life Sciences II Inc. filed SEC Form 8-K: Financial Statements and Exhibits

    8-K - Columbus Circle Capital Corp II (0002088805) (Filer)

    2/26/26 4:55:40 PM ET
    $CMII
    Blank Checks
    Finance

    CM Life Sciences II Inc. filed SEC Form 8-K: Leadership Update

    8-K - Columbus Circle Capital Corp II (0002088805) (Filer)

    2/19/26 4:32:06 PM ET
    $CMII
    Blank Checks
    Finance

    $CMII
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Columbus Circle 2 Sponsor Corp Llc bought $2,650,000 worth of Class A ordinary shares (265,000 units at $10.00) (SEC Form 4)

    4 - Columbus Circle Capital Corp II (0002088805) (Issuer)

    2/17/26 8:42:53 PM ET
    $CMII
    Blank Checks
    Finance

    SEC Form 3 filed by new insider Alsina Gonzalez Alberto

    3 - Columbus Circle Capital Corp II (0002088805) (Issuer)

    2/10/26 9:48:19 PM ET
    $CMII
    Blank Checks
    Finance

    SEC Form 3 filed by new insider Murphy Matthew Joseph

    3 - Columbus Circle Capital Corp II (0002088805) (Issuer)

    2/10/26 9:47:48 PM ET
    $CMII
    Blank Checks
    Finance

    $CMII
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Columbus Circle 2 Sponsor Corp Llc bought $2,650,000 worth of Class A ordinary shares (265,000 units at $10.00) (SEC Form 4)

    4 - Columbus Circle Capital Corp II (0002088805) (Issuer)

    2/17/26 8:42:53 PM ET
    $CMII
    Blank Checks
    Finance

    $CMII
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by CM Life Sciences II Inc.

    SC 13G - SomaLogic, Inc. (0001837412) (Subject)

    10/8/21 4:07:06 PM ET
    $CMII
    Blank Checks
    Finance

    SEC Form SC 13G/A filed by CM Life Sciences II Inc. (Amendment)

    SC 13G/A - SomaLogic, Inc. (0001837412) (Subject)

    9/24/21 4:58:16 PM ET
    $CMII
    Blank Checks
    Finance

    SEC Form SC 13D filed by CM Life Sciences II Inc.

    SC 13D - SomaLogic, Inc. (0001837412) (Subject)

    9/15/21 6:20:38 AM ET
    $CMII
    Blank Checks
    Finance